LCM Capital Management Inc
Source: SEC Form 13F · as of Mar 2026LCM Capital Management Inc holds 14 biotech & pharma companies tracked by BioSniper, totaling $7.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$7.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for JOHNSON & JOHNSON (JNJ)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 10,551 | $2.6M |
| GILDGILEAD SCIENCES, INC. | 8,828 | $1.2M |
| AMRNAMARIN CORP PLCUK | 43,462 | $628K |
| BMYBRISTOL MYERS SQUIBB CO | 8,885 | $539K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,158 | $517K |
| NVSNovartis AG | 3,272 | $500K |
| REGNREGENERON PHARMACEUTICALS, INC. | 581 | $449K |
| PMPhilip Morris International Inc | 2,514 | $416K |
| PFEPFIZER INC | 14,107 | $396K |
| AMGNAMGEN INC | 1,008 | $355K |
| LLYELI LILLY & Co | 218 | $201K |
| NUVBNuvation Bio Inc. | 15,000 | $64K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 12,000 | $37K |
| GERNGERON CORP | 20,400 | $30K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.